Skip to content

Prospective Clinical Study of Different Intraocular Lens Implantation Designed for the Correction of Presbyopia

Prospective Clinical Study of Different Intraocular Lens Implantation Designed for the Correction of Presbyopia

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04265846
Enrollment
140
Registered
2020-02-12
Start date
2020-05-31
Completion date
2022-11-01
Last updated
2022-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract Senile, Presbyopia

Brief summary

Compare postoperative Subjective and objective visual quality and economic efficiency of different Intraocular Lens(IOLs) implantation designed for the correction of presbyopia.

Detailed description

Compare postoperative Subjective and objective visual quality and economic efficiency of different Intraocular Lens Implantation designed for the correction of presbyopia.The subjects will undergo bilateral uneventful phacoemulsification and implantation of IOL.The subjects will be divided into several groups according to the type of the IOLs,including monofocal IOL group,monovision designed group ,bifocal IOL group, mix bifocal IOL group,trifocal IOL group,Exteded Depth of Focus(EDOF) IOL group and blend vision group. Compare the Subjective and objective visual quality and economic efficiency among these groups at 3 months postoperatively.

Interventions

The patients will undergo bilateral phacoemulsification and bifocal IOLs implantation.

DEVICEmix bifocal IOL

The patients will undergo phacoemulsification and mix different bifocal IOLs implantation bilaterally.

The patients will undergo bilateral phacoemulsification and trifocal IOLs implantation.

DEVICEEDOF IOL

The patients will undergo bilateral phacoemulsification and EDOF IOLs implantation.

DEVICEdifferent IOLs

The patients will undergo phacoemulsification and different IOLs implantation bilaterally.

The patients will undergo bilateral phacoemulsification and monofocal IOLs implantation with monovision designed.

Sponsors

People's Hospital of Guangxi Zhuang Autonomous Region
CollaboratorOTHER
Peking University Third Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients with bilateral cataract * Regular corneal topography and Preoperative corneal astigmatism ≤ 0.75 Diopter

Exclusion criteria

* Pregnant or nursing women * In the presence of other ocular diseases that may affect the stability of the lens capsule (pseudoexfoliation syndrome, glaucoma, traumatic cataract, Marfan syndrome, etc.) * Pupil abnormality (non-reactive pupil, tonic pupils, abnormally shaped pupils, etc.) * History of any clinically significant retinal pathology or ocular diagnosis (e.g. diabetic retinopathy, ischemic diseases, macular degeneration, retinal detachment, optic neuropathy optic nerv atrophy, amblyopia, strabismus, microphthalmos, aniridia, epiretinal membrane etc.) in the study eyes that could alter or limit final postoperative visual prognosis. * Patients with history of ocular trauma or prior ocular surgery including refractive procedures * postoperative visual acuity of worse than 0.2 logMAR in any eye * Patients using systemic or ocular medication that affect visual acuity. * Patients participating in other clinical trials during the study.

Design outcomes

Primary

MeasureTime frameDescription
monocular and binocular visual acuity3 months postoperativelyuncorrected distance visual acuity (UCVA), intermediate visual acuity, near visual acuity will be measured at 5m, 80cm and 40cm respectively. All visual acuity measurements will be conducted under photopic conditions (85 cd/m2) and at 100% contrast
economic efficiency3 months postoperativelyeconomic efficiency was defined as the ratio of objective spectacle independence (UCVA better than 0.10 logMAR) and IOL price, then compare the economic efficiency among different groups.

Secondary

MeasureTime frameDescription
stereopsis3 months postoperativelydistant stereopsis will be measured by block diagram of random-spot synoptophore, while near stereopsis will be measured by Yan's stereogram.
Binocular Contrast sensitivity3 months postoperativelyContrast sensitivity measures will be conducted binocularly, under photopic, mesopic (5 cd/m2), photopic with glare and mesopic with glare conditions, with the OPTEC 6500 contrast sensitivity test (Stereo Optical, USA). Contrast sensitivity will be evaluated at five spatial frequencies (1.5, 3, 6, 12, and 18 cycles per degree \[cpd\]). Patients will be allowed 5 minutes to adapt to each illumination level before testing.
Subjective visual quality3 months postoperativelyUsing NEI-VFQ-25 questionnaire (Chinese version). Photic phenomena, spectacle independence, and satisfaction questionnaire.
Fusion function3 months postoperativelyThe fusion function of perception and movement (convergence and divergence)will be examined with a synoptophore.
Binocular Defocus Curve3 months postoperativelyBinocular defocus curves will be obtained in all patients, positioned at 5m under photopic (\>85 cd/m 2 ) condition to measure the visual acuity with each defocus lens, representing the consecutive visual function of each eye. Negative lenses were added in 0.50 D steps and the visual acuity will be recorded for each type of defocus level. The procedure will be then repeated but with positive lenses. The range of defocus evaluated is from -4.00D to +2.00D.

Countries

China

Contacts

Primary ContactQianqian Lan
54283122@qq.com+8618607711972

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026